A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis
Clinical trial NCT04444752 · COMPLETED
Trial details
- NCT number
- NCT04444752
- Sponsor
- Connect Biopharm LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-17
- Primary completion
- 2021-07-28
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.